Sanna, G.; Marongiu, A.; Firinu, D.; Piras, C.; Franci, G.; Galdiero, M.; Pala, G.; Palmas, V.; Angius, F.; Littera, R.;
et al. Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination. Vaccines 2022, 10, 531.
https://doi.org/10.3390/vaccines10040531
AMA Style
Sanna G, Marongiu A, Firinu D, Piras C, Franci G, Galdiero M, Pala G, Palmas V, Angius F, Littera R,
et al. Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination. Vaccines. 2022; 10(4):531.
https://doi.org/10.3390/vaccines10040531
Chicago/Turabian Style
Sanna, Giuseppina, Alessandra Marongiu, Davide Firinu, Cristina Piras, Gianluigi Franci, Massimiliano Galdiero, Giuseppe Pala, Vanessa Palmas, Fabrizio Angius, Roberto Littera,
and et al. 2022. "Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination" Vaccines 10, no. 4: 531.
https://doi.org/10.3390/vaccines10040531
APA Style
Sanna, G., Marongiu, A., Firinu, D., Piras, C., Franci, G., Galdiero, M., Pala, G., Palmas, V., Angius, F., Littera, R., Perra, A., Orrù, G., Campagna, M., Costanzo, G., Meloni, F., Coghe, F., Chessa, L., & Manzin, A.
(2022). Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination. Vaccines, 10(4), 531.
https://doi.org/10.3390/vaccines10040531